BioPearl™ Microspheres Loaded With Doxorubicin for the Treatment of Unresectable Hepatocellular Carcinoma (HCC)

This study is testing BioPearl microspheres — tiny beads loaded with chemotherapy (doxorubicin) — delivered directly into the blood vessels feeding a liver tumor. This approach tries to kill the tumor while limiting side effects to the rest of the body. **You may be eligible if...** - You are 18 or older - You have confirmed liver cancer (hepatocellular carcinoma) - Your tumor(s) are under 5 cm and meet specific size criteria (up-to-7 rule) - Your liver is still functioning reasonably well (Child-Pugh A or B7) - Surgery or ablation is not a suitable option for you **You may NOT be eligible if...** - Your cancer has spread outside the liver to other organs - You have very poor liver function - You have had a liver transplant or previous similar treatment Talk to your doctor to see if this trial is right for you.